You are now leaving the Lilly Medical Education website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.
Chronic Lymphocytic Leukemia (CLL) and Supportive Care
Explore our educational resources on CLL disease state and supportive care.
Date of Last Review: May 29, 2026
Document Number: VV-MED-143938
Related Resources
Infographic for HCPs to counsel patients with CLL about infection prevention, staying up to date with vaccines, and screening for second primary malignancies.
This infographic discusses the need for a tailored, patient-centered approach to addressing common conditions and risk factors to consider for long-term survivorship care of patients living with CLL.
This infographic explores polypharmacy in CLL, highlighting reduction strategies and a patient-centered approach.
This slide deck provides an overview of comorbidities and concomitant conditions in patients with CLL, offering best practices and treatment considerations to guide multidisciplinary care and optimize patient outcomes.
This infographic emphasizes the importance of effective communication, self-advocacy, and education in positively impacting the quality of life and clinical outcomes for CLL patients.
This infographic is intended to provide Health Care Providers with an overview of biomarkers and provide insight into a patient's risk stratification and potential response to CLL therapies.
This infographic is intended to provide Health Care Providers with an overview on Chronic Lymphocytic Leukemia (CLL).
This slide deck is intended to educate Health Care Providers about strategies, solutions, and resources for incorporating new treatments into clinical practice for B-cell malignancies.
In this slide deck, HCPs will gain deeper knowledge of Chronic Lymphocytic Leukemia (CLL) including epidemiology, biology & cytogenetics, and detection & diagnosis.
This infographic is intended to provide Health Care Providers with an overview on Chronic Lymphocytic Leukemia (CLL).
In this slide deck, HCPs will gain deeper knowledge of understanding High-Risk CLL in the Era of Targeted Therapies
This infographic is intended to provide Health Care Providers information on Best Practices for Managing BTK Inhibitors in Patients with a history of Cardiac Comorbidities.
In this slide deck, HCPs will gain deeper knowledge of appropriate assessment, monitoring, and management of cardiotoxicity-associated complications for optimal use of BTK inhibitors in CLL, particularly in patients with baseline risk factors.
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied